These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2028714)

  • 1. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
    Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
    Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
    Gjessing HJ; Reinholdt B; Pedersen O
    Diabetologia; 1989 Dec; 32(12):858-63. PubMed ID: 2693165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic hyperglycaemia on the islet B-cell responsiveness in newly diagnosed type 2 diabetes.
    Gjessing HJ; Reinhold B; Pedersen O
    Diabet Med; 1992; 9(7):601-4. PubMed ID: 1511564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
    Uitbeijerse BS; Nijhoff MF; de Koning EJP
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM.
    Dupre J; Behme MT; Hramiak IM; McFarlane P; Williamson MP; Zabel P; McDonald TJ
    Diabetes; 1995 Jun; 44(6):626-30. PubMed ID: 7789625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
    Banerji MA
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
    Starostina EG; Lobanova AM; Magomedova AK
    Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
    Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
    Ahrén B; Holst JJ; Mari A
    Diabetes Care; 2003 Oct; 26(10):2860-4. PubMed ID: 14514592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
    Heaton DA; Lazarus NR; Pyke DA; Leslie RD
    Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
    Dupre J; Jenner MR; Mahon JL; Purdon C; Rodger NW; Stiller CR
    Diabetes; 1991 May; 40(5):598-604. PubMed ID: 2022304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
    Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.